Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Simultaneous crosslinking of CD20 and CD38 receptors by drug-free macromolecular therapeutics enhances B cell apoptosis in vitro and in vivo

Published:2022-10 Issue: Volume:350 Page:584-599
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Tommy Gambles M.,Li Jiahui,Christopher Radford D.,Sborov Douglas,Shami Paul,Yang Jiyuan,Kopeček Jindřich

Funder

Huntsman Cancer Institute

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference61 articles.

1. 2016 US lymphoid malignancy statistics by World Health Organization subtypes;Teras;CA Cancer J. Clin.,2016

2. Inherited susceptibility to hematopoietic malignancies in the era of precision oncology;Roloff;JCO Precision Oncol.,2021

3. Nanomedicines in B cell-targeting therapies;Wang;Acta Biomater.,2022

4. The evolution of hematopoietic cells under cancer therapy;Pich;Nat. Commun.,2021

5. Monoclonal antibody therapies for hematological malignancies: not just lineage-specific targets;Cuesta-Mateos;Front. Immunol.,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hydrophilic biomaterials: From crosslinked and self-assembled hydrogels to polymer-drug conjugates and drug-free macromolecular therapeutics;Journal of Controlled Release;2024-09

2. Multiantigen T-Cell Hybridizers: A Two-Component T-Cell-Activating Therapy;ACS Nano;2024-08-16

3. Human serum albumin-based drug-free macromolecular therapeutics induce apoptosis in chronic lymphocytic leukemia patient cells by crosslinking of CD20 and/or CD38 receptors;Drug Delivery and Translational Research;2024-05-27

4. Management of Cardiovascular Complications in Antiphospholipid Syndrome: A Narrative Review with a Focus on Older Adults;Journal of Clinical Medicine;2024-05-23

5. Obinutuzumab‐Based Drug‐Free Macromolecular Therapeutics Synergizes with Topoisomerase Inhibitors;Macromolecular Bioscience;2023-10-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3